Business Wire

CO-WESTERN-UNION-COMPANY

30.4.2021 23:10:10 CEST | Business Wire | Press release

Share
Western Union Supports India COVID Relief

The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, and the Western Union Foundation today announced a package of relief efforts for India aimed at combating its latest, devastating phase in the COVID-19 pandemic, and kicked off a fundraising appeal with Western Union employees worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210430005585/en/

In collaboration with United Way India (UWI), the Western Union Foundation will fund medical respiratory support machines for hospitals and at-home care kits for families, expected to benefit up to 5,000 households in the Maharashtra region immediately. Beginning May 4th , Western Union will also waive transfer fees*—for two weeks for digital channels, and four weeks for retail channels—for monies sent by family and friends from select countries directly into Indian bank accounts.

“We stand in solidarity with the people of India as they confront this latest phase of the COVID-19 pandemic. Our thoughts and prayers are with our customers, our agents, our employees and their families,” said Sohini Rajola, Head of Regional Network, Middle East and APAC.

“The people of India, my home nation, are showing remarkable courage and resilience. We are comforted that the financial support of the Western Union Foundation and our zero-fee action will contribute to much-needed medical relief and facilitate additional financial flows into the country, supporting people’s everyday needs, including medicine and health care,” she said.

“A core mission of the Western Union Foundation is the support of vulnerable people in times of extreme need,” said Executive Director Elizabeth Roscoe. “Working with United Way India, we are hopeful that our resources will help the people of the Maharashtra region as they grapple with this crisis.

“We also want to extend our deepest gratitude to local emergency and health care workers, whose efforts in the face of unimaginable difficulty are an ongoing inspiration to people everywhere,” Roscoe said.

Western Union Foundation & United Way India

UWI, in conjunction with large government hospitals, will manage the distribution of respiratory support machines such as non-invasive ventilators and oxygen generators, which are critically required at hospitals—particularly to help support patients who are in the moderately severe category from getting worse.

UWI will also deliver at-home care kits suitable to treat non-critical COVID patients outside the hospital by equipping them with COVID monitoring techniques, oximeters to monitor blood oxygen levels, and thermometers. The at-home care kits enable families to monitor their symptoms without a hospital trip that risks exposure and further burdening already overwhelmed health care facilities. This program will primarily serve underprivileged patients across the hardest-hit, most remote, and lowest-income communities in the region.

The Western Union Foundation has committed $200,000 to the United Way India for this effort (NOTE: assuming all the funds will be given to UWI directly). Further, all funds raised by the Foundation’s Western Union employee appeal will be granted to UWI, with the goal of raising an additional $50,000.

Western Union Zero-transfer fee to Indian Bank Accounts

Commencing May 4th , 2021, Western Union will waive transfer fees* to Indian bank accounts, for two weeks for digital channels, through May 18th ; and four weeks for retail channels, through June 4th . To avail themselves of the offer, customers must send money directly into Indian bank accounts via westernunion.com and the Western union mobile app from Canada, Europe & CIS and the U.S.; and from retail agent locations across Australia, Canada, Europe & CIS, New Zealand and the U.S.**

About Western Union

The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Western Union’s platform provides seamless cross-border flows and its leading global financial network bridges more than 200 countries and territories and over 130 currencies. We connect businesses, financial institutions, governments, and consumers through one of the world’s widest reaching networks, accessing billions of bank accounts, millions of digital wallets, and cards, and over half a million retail locations. Western Union connects the world to bring boundless possibilities within reach. For more information, visit www.westernunion.com .

About the Western Union Foundation

The Western Union Foundation believes that education is the surest pathway to economic opportunity. After 20 years of impact, we continue to deliver on our mission with Opportunity Beyond Borders, focused on empowering forcibly displaced and marginalized youth with the training and education needed to succeed in today’s technology-driven global economy. The Foundation also provides funding for humanitarian efforts for communities in crisis and disaster, one key reason for forced migration. To date, we have funded more than $131 million for projects and scholarships. The Western Union Foundation is a separate, tax-exempt 501(c)(3) charitable corporation and receives support from The Western Union Company, its employees, agents, and business partners. Contributions to the Foundation are tax-deductible for U.S. income tax purposes. To learn more, visit wu.com/foundation or follow us on Twitter @TheWUFoundation.

*Western Union also makes money from currency exchange. When choosing a money transmitter, carefully compare both transfer fees and exchange rates. Fees, foreign exchange rates, and taxes may vary by brand, channel, and location-based on several factors. Fees and rates subject to change without notice.

** Consumers in the U.S. and Canada were previously offered zero-transfer fee transactions into India when sending digitally for Account Payout.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents23.4.2026 13:29:00 CEST | Press release

Mangaciclanol, if approved, could transform contrast-enhanced MR imaging by offering an alternative to - or even replacing - gadolinium-based MRI agentsA manganese-based MRI contrast agent could address concerns with gadolinium-based contrast agents around retention in the body, security of supply, and the environment, with mangaciclanol’s clinical development under FDA Fast Track designationThe program demonstrates GE HealthCare’s commitment to advancing novel imaging agents to address unmet patient needs GE HealthCare (Nasdaq: GEHC) today announced the first patient has been dosed in the international, multi-center Phase 2/3 LUMINA clinical trial of its manganese-based magnetic resonance imaging (MRI) contrast agent, mangaciclanol, at Mayo Clinic in Rochester, Minnesota. Mangaciclanol, if approved, could offer an alternative to – or even replace – gadolinium-based MRI contrast agents, the current standard of care. The investigational agent has been granted Fast Track designation by t

Croma Pharma Launches AI-Driven Tech Venture to Revolutionize Aesthetic Medicine via Clinicore Platform23.4.2026 13:13:00 CEST | Press release

New structure to drive AI-powered innovation and international expansion Croma Pharma has launched a strategic joint venture to accelerate the development of Clinicore, its premium digital solution for aesthetic practices. This dedicated entity will focus on scaling the next generation of the platform while ensuring full continuity for existing users. Clinicore: Elevating Practice Excellence through AI Clinicore is a specialized SaaS (Software as a Service) solution designed to optimize the daily operations of aesthetic clinics. By automating patient management, scheduling, and administrative workflows, it enables healthcare professionals to focus entirely on patient care. A core element of the new strategy is a strong focus on Artificial Intelligence. Clinicore is evolving into a smart assistant, utilizing AI-driven features for automated treatment documentation, intelligent onboarding tools, and advanced process automation. This ensures that clinics can operate at maximum efficiency

NIQ Launches Commerce Lab to Build the Data and Measurement Layer for AI-Driven Commerce23.4.2026 13:00:00 CEST | Press release

NielsenIQ (NYSE: NIQ) today announced the launch of NIQ Commerce Lab, where the company is building the technology infrastructure for AI-driven commerce. The Lab will develop the data platforms, APIs, and measurement systems that power how products are discovered, evaluated, and purchased in AI-mediated environments. This includes what the industry often refers to as agentic commerce, but extends across quick commerce, social commerce, and other emerging channels—where AI is becoming the common layer shaping how consumers navigate choices and how decisions are made in real time. AI systems are rapidly moving from supporting decisions to making them—playing an increasingly central role in how commerce operates. Their effectiveness depends on the intelligence behind them. AI is Becoming the Operating Layer of Global Commerce NIQ ensures that the intelligence behind these systems is accurate, complete, and grounded in real-world behavior—reflecting how consumers actually buy, what product

Chiesi Reports Strong FY2025 Financial and Sustainability Results and Announces Leadership Transition Highlights23.4.2026 12:10:00 CEST | Press release

Strong FY2025 financial and sustainability results; leadership transition will support continuity and long-term growth Revenue up 8.2% to €3.6bn with double-digit growth in Rare Diseases and U.S. market Air sales at €1.886bn, growing 3.9% vs. 2024 - Care sales at €904m growing 13.3% vs. 2024 - Rare sales at €906m, growing 22.3% vs. 2024 Giuseppe Accogli leaving to pursue another opportunity, Group CFO Jean-Marc Bellemin named Interim CEO while new CEO search is underway Record €885m Research & Development (R&D) investment underscores continued commitment to innovation across respiratory, rare disease and specialty care Sustainability leadership further strengthened through B Corp recertification and progress on Carbon Minimal Inhaler (CMI) innovation Chiesi Group (“Chiesi”), an international research‑focused biopharmaceutical company and certified B Corp, today announced its financial results for the year ended 31 December 2025. Chiesi reported €3.625 billion in consolidated revenues,

REPLY S.p.A.: Shareholders’ Meeting Approves the 2025 Financial Statements23.4.2026 12:05:00 CEST | Press release

Consolidated turnover of €2,483.6 million (€2,300.5 million in 2024);Group net profits of €250.9 million (€211.1 million in 2024).Approval of the proposal to distribute a dividend of €1.35 per share.Approval of the plan for the purchase and/or disposal of treasury shares. The General Shareholders’ meeting of Reply S.p.A. [EXM, STAR: REY] held today approved the Financial Statements for the financial year 2025, confirming the distribution of a gross dividend of €1.35 per share. The dividend will be paid on 20 May 2026, with dividend date set on 18 May 2026 (record date on 19 May 2026). Approval of the 2025 financial statements The Reply Group closed the 2025 financial year with a consolidated turnover of €2,483.6 million, recording a 8.0% increase compared to €2,300.5 million in 2024. Consolidated EBITDA was €467.6 million, up 13.9% compared to €410.6 million recorded for the year 2024. EBIT, from January to December, was €397.1 million, up 18.5% compared to €330.4 million recorded for

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye